UBS Maintains a 'Buy' on HCA Holdings (HCA); Solid Quarter, Guidance In-line

February 7, 2012 11:20 AM EST
Get Alerts HCA Hot Sheet
Price: $404.68 -1.71%

Rating Summary:
    23 Buy, 11 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Buy' on HCA Holdings (NYSE: HCA) price target raised from $26 to $35.

UBS analyst says, "In terms of read-thru’s from qtr, it appeared that Q4 looked much like Q3 in terms of better volumes offset by weaker mix/pricing and although improving jobs #’s clearly a positive trend for future utilization, we remain unconvinced of a turn in NT. Looking ahead, key here will be how confluence of easy mix/pricing comps beginning in Q2 play against tougher cost control comps beginning in Q3. We continue to remain positively biased on HCA with $2 special div high lighting public/private shareholder alignment."

UBS raises FY12 EPS estimate from $3.46 to 3.51 and FY13 from $3.65 to $3.75.

For an analyst ratings summary and ratings history on HCA Holdings click here. For more ratings news on HCA Holdings click here.

Shares of HCA Holdings closed at $28.40 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

UBS